Literature DB >> 28490223

Molecular remodeling of the renin-angiotensin system after kidney transplantation.

Marlies Antlanger1, Oliver Domenig1, Johannes J Kovarik1, Christopher C Kaltenecker1, Chantal Kopecky1, Marko Poglitsch2, Marcus D Säemann1.   

Abstract

OBJECTIVE: We aimed at assessing the molecular adaptation of the renin-angiotensin system (RAS) after successful kidney transplantation (KTX).
MATERIALS AND METHODS: In this prospective, exploratory study we analyzed 12 hemodialysis (HD) patients, who received a KTX and had excellent graft function six to 12 months thereafter. The concentrations of plasma Angiotensin (Ang) peptides (Ang I, Ang II, Ang-(1-7), Ang-(1-5), Ang-(2-8), Ang-(3-8)) were simultaneously quantified with a novel mass spectrometry-based method. Further, renin and aldosterone concentrations were determined by standard immunoassays.
RESULTS: Ang values showed a strong inter-individual variability among HD patients. Yet, despite a continued broad dispersion of Ang values after KTX, a substantial improvement of the renin/Ang II correlation was observed in patients without RAS blockade or on angiotensin receptor blocker (HD: renin/Ang II R2 = 0.660, KTX: renin/Ang II R2 = 0.918). Ang-(1-7) representing the alternative RAS axis was only marginally detectable both on HD and after KTX.
CONCLUSIONS: Following KTX, renin-dependent Ang II formation adapts in non-ACE inhibitor-treated patients. Thus, a largely normal RAS regulation is reconstituted after successful KTX. However, individual Ang concentration variations and a lack of potentially beneficial alternative peptides after KTX call for individualized treatment. The long-term post-transplant RAS regulation remains to be determined.

Entities:  

Keywords:  Renin-angiotensin system; angiotensin; blood pressure; hemodialysis; kidney transplantation

Mesh:

Substances:

Year:  2017        PMID: 28490223      PMCID: PMC5843863          DOI: 10.1177/1470320317705232

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  43 in total

1.  The regulation of aldosterone secretion in man: the role of fluid volume.

Authors:  J K BARBER; F C BARTTER; C DELEA; L E DUNCAN; G W LIDDLE
Journal:  J Clin Invest       Date:  1956-11       Impact factor: 14.808

2.  PARADIGM-HF--the experts' discussion.

Authors:  Mariell Jessup; Keith A A Fox; Michel Komajda; John J V McMurray; Milton Packer
Journal:  N Engl J Med       Date:  2014-09-03       Impact factor: 91.245

Review 3.  New agents modulating the renin-angiotensin-aldosterone system-Will there be a new therapeutic option?

Authors:  Anna Gromotowicz-Poplawska; Piotr Szoka; Patrycjusz Kolodziejczyk; Karol Kramkowski; Marzena Wojewodzka-Zelezniakowicz; Ewa Chabielska
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-19

4.  Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study.

Authors:  Domingo Hernández; Alfonso Muriel; Víctor Abraira; Germán Pérez; Esteban Porrini; Domingo Marrero; Javier Zamora; José Manuel González-Posada; Patricia Delgado; Margarita Rufino; Armando Torres
Journal:  Nephrol Dial Transplant       Date:  2011-05-28       Impact factor: 5.992

5.  Angiotensin converting enzyme inhibitor use soon after renal transplantation: a randomized, double-blinded placebo-controlled safety study.

Authors:  Daniel Glicklich; Roberto Gordillo; Katarina Supe; Raquel Tapia; Robert Woroniecki; Clemencia Solorzano; Maria Coco
Journal:  Clin Transplant       Date:  2010-12-16       Impact factor: 2.863

6.  Transplantation: The role of RAAS blockade in kidney transplantation.

Authors:  Robert D Toto
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

7.  Effects of kidney transplantation on the renin-angiotensin systems of the recipients.

Authors:  R Rettig; M Büch; R Gerstberger; P Schnatterbeck; M Paul
Journal:  Kidney Int       Date:  1994-12       Impact factor: 10.612

8.  The Association Between Renin-Angiotensin System Blockade and Long-term Outcomes in Renal Transplant Recipients: The Wisconsin Allograft Recipient Database (WisARD).

Authors:  Jung-Im Shin; Mari Palta; Arjang Djamali; Dixon B Kaufman; Brad C Astor
Journal:  Transplantation       Date:  2016-07       Impact factor: 4.939

Review 9.  Hypertension in dialysis and kidney transplant patients.

Authors:  G V Ramesh Prasad; Marcel Ruzicka; Kevin D Burns; Sheldon W Tobe; Marcel Lebel
Journal:  Can J Cardiol       Date:  2009-05       Impact factor: 5.223

10.  Quantification of systemic renin-angiotensin system peptides of hypertensive black and white African men established from the RAS-Fingerprint®.

Authors:  J M van Rooyen; M Poglitsch; H W Huisman; Cmc Mels; R Kruger; L Malan; S Botha; L Lammertyn; L Gafane; A E Schutte
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2016-10-12       Impact factor: 1.636

View more
  4 in total

1.  Progression of diabetic kidney disease in T2DN rats.

Authors:  Oleg Palygin; Denisha Spires; Vladislav Levchenko; Ruslan Bohovyk; Mykhailo Fedoriuk; Christine A Klemens; Olga Sykes; John D Bukowy; Allen W Cowley; Jozef Lazar; Daria V Ilatovskaya; Alexander Staruschenko
Journal:  Am J Physiol Renal Physiol       Date:  2019-09-30

2.  Postprandial Effects on ENaC-Mediated Sodium Absorption.

Authors:  Gregory Blass; Christine A Klemens; Michael W Brands; Oleg Palygin; Alexander Staruschenko
Journal:  Sci Rep       Date:  2019-03-12       Impact factor: 4.996

3.  Intrarenal Renin-Angiotensin-System Dysregulation after Kidney Transplantation.

Authors:  Johannes J Kovarik; Christopher C Kaltenecker; Chantal Kopecky; Oliver Domenig; Marlies Antlanger; Johannes Werzowa; Farsad Eskandary; Renate Kain; Marko Poglitsch; Sabine Schmaldienst; Georg A Böhmig; Marcus D Säemann
Journal:  Sci Rep       Date:  2019-07-05       Impact factor: 4.379

4.  Relationship between the renin-angiotensin-aldosterone system and renal Kir5.1 channels.

Authors:  Anna D Manis; Oleg Palygin; Sherif Khedr; Vladislav Levchenko; Matthew R Hodges; Alexander Staruschenko
Journal:  Clin Sci (Lond)       Date:  2019-12-20       Impact factor: 6.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.